Howard Davis is the founder of Akamis Bio. Akamis Bio has raised $90M in total funding. Latest round: Series A. Based in Cambridge, MA.
Howard E. Davis, Ph.D. is the Chief Executive Officer of Akamis Bio, a clinical-stage oncology company. He joined Akamis Bio in July 2022 following its rebranding from PsiOxus Therapeutics and the announcement of a $30 million convertible note financing.
Full founder directory · Investor directory · Company funding database · Fundraising library